Physician profile
Robert T Bents
NPI 1275516593
$6,912.16
in general payments reported to CMS, 2019-2025
8 companies · $36.33 in 2025
The $36.33 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,360 · 2020: $3,000 · 2021: $304 · 2022: $1,262 · 2023: $79.25 · 2024: $871 · 2025: $36.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $695 · Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $695.32 |
| Food and Beverage | $291.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,282.15 | 2020-2025 | Inspace, Iconix, Aequalis Perform |
| Steelhead Surgical INC | $2,050.06 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $764.38 | 2019-2021 | |
| Arthrex, INC. | $717.57 | 2020-2024 | Arthrex |
| Medical Device Business Services, INC. | $32.82 | 2022 | |
| Organogenesis INC. | $31.25 | 2024 | Puraply Wound Matrix |
| Vericel Corporation | $18.87 | 2020 | |
| Sanofi-Aventis U.S. LLC | $15.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bents listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.